ID

31204

Description

Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT01687439

Lien

https://clinicaltrials.gov/show/NCT01687439

Mots-clés

Versions (1)
  1. 28/07/2018 28/07/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

28 juillet 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-small Cell Lung Cancer NCT01687439

Anglais

Eligibility Non-small Cell Lung Cancer NCT01687439

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically proven inoperable stage iiib-iv nsclc
Description

Non-Small Cell Lung Carcinoma Inoperable TNM clinical staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205187
UMLS CUI [1,3]
C3258246
ecog ps 0-1
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy > 3 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
adequate blood functions: absolute neutrophil count (anc) ≥ 1.5 x 109/l, platelet count ≥ 100 x 109/l, and hemoglobin ≥ 9 g / dl
Description

Hematologic function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
adequate liver function: total bilirubin <1.5 times the upper limit of normal (uln); ast and alt <2.5 times uln in patients without liver metastases, <5 times uln in patients with liver metastases
Description

Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver Present

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
UMLS CUI [5,1]
C0494165
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0494165
UMLS CUI [6,2]
C0150312
adequate renal function: serum creatinine ≤ 1.25 times uln or calculated creatinine clearance ≥ 50 ml / min and urinary protein <2+. in patients with baseline urinary protein ≥ 2+, 24 hours urine should be collected and 24 hours urine protein ≤ 1g
Description

Renal function | Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula | Proteinuria | 24 hour urine sample | 24 Hour urine volume measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
UMLS CUI [3]
C2711451
UMLS CUI [4]
C0033687
UMLS CUI [5]
C0456209
UMLS CUI [6]
C0427843
international normalized ratio (inr) ≤ 1.5 and prothrombin time(pt) ≤ 1.5 times uln within 7 days before enrollment
Description

International Normalized Ratio | Prothrombin time assay

Type de données

boolean

Alias
UMLS CUI [1]
C0525032
UMLS CUI [2]
C0033707
written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of bleeding diathesis or coagulopathy
Description

Bleeding tendency | Blood Coagulation Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0005779
history of hemoptysis, defined as bright red blood more than half a teaspoon 3 months before enrollment
Description

Hemoptysis

Type de données

boolean

Alias
UMLS CUI [1]
C0019079
previously received chemotherapy and radiotherapy and biological targeted therapy
Description

Prior Chemotherapy | Prior radiation therapy | Targeted Therapy biological

Type de données

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2]
C0279134
UMLS CUI [3,1]
C2985566
UMLS CUI [3,2]
C0205460
uncontrolled hypertension (systolic blood pressure> 150 mmhg and/or diastolic blood pressure> 100 mm hg)
Description

Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure

Type de données

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
clinically significant (ie, active) cardiovascular diseases, such as cerebrovascular accident (within 6 months before initiating treatment), myocardial infarction (within 6 months before initiating treatment), unstable angina, congestive heart failure (new york heart association class ≥grade ii) , serious arrhythmia which needs medication during the study and may affect the study or can not be controlled by drugs
Description

Cardiovascular Diseases | Cerebrovascular accident | Myocardial Infarction | Angina, Unstable | Congestive heart failure New York Heart Association Classification | Cardiac Arrhythmia Serious Requirement Pharmaceutical Preparations | Cardiac Arrhythmia Affecting Clinical Trial | Cardiac Arrhythmia Pharmacotherapy Unsuccessful

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0027051
UMLS CUI [4]
C0002965
UMLS CUI [5,1]
C0018802
UMLS CUI [5,2]
C1275491
UMLS CUI [6,1]
C0003811
UMLS CUI [6,2]
C0205404
UMLS CUI [6,3]
C1514873
UMLS CUI [6,4]
C0013227
UMLS CUI [7,1]
C0003811
UMLS CUI [7,2]
C0392760
UMLS CUI [7,3]
C0008976
UMLS CUI [8,1]
C0003811
UMLS CUI [8,2]
C0013216
UMLS CUI [8,3]
C1272705
unhealed wounds, active peptic ulcer or fracture
Description

Wound, non-healed | Peptic Ulcer | Fracture

Type de données

boolean

Alias
UMLS CUI [1]
C0750433
UMLS CUI [2]
C0030920
UMLS CUI [3]
C0016658
gastrointestinal fistula, gastrointestinal perforation or intra-abdominal abscess within 6 months before enrollment
Description

Digestive System Fistula | Gastrointestinal perforation | Abdominal Abscess

Type de données

boolean

Alias
UMLS CUI [1]
C0079238
UMLS CUI [2]
C0151664
UMLS CUI [3]
C0243001
women with intact uterus (menopause more than two years excluded) who are unwilling to take effective non-hormonal contraception (iud, spermicide barrier birth control device or sterilization) during the study. male who are unwilling to take effective contraceptive measures during the study
Description

Gender Uterus Intact | Menopause Excluded | Contraceptive methods Unwilling | Intrauterine Devices | Vaginal Spermicides | Contraception, Barrier | Female Sterilization | Gender Contraceptive methods Unwilling

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0042149
UMLS CUI [1,3]
C0205266
UMLS CUI [2,1]
C0025320
UMLS CUI [2,2]
C0332196
UMLS CUI [3,1]
C0700589
UMLS CUI [3,2]
C0558080
UMLS CUI [4]
C0021900
UMLS CUI [5]
C0087145
UMLS CUI [6]
C0004764
UMLS CUI [7]
C0015787
UMLS CUI [8,1]
C0079399
UMLS CUI [8,2]
C0700589
UMLS CUI [8,3]
C0558080
participated in other clinical trials within 28 days before the initiation of treatment.
Description

Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
allergic to any of the study drugs
Description

Hypersensitivity Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
Retour au début de la page

Similar models

Eligibility Non-small Cell Lung Cancer NCT01687439

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Inoperable TNM clinical staging
Item
histologically or cytologically proven inoperable stage iiib-iv nsclc
boolean
C0007131 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
ECOG performance status
Item
ecog ps 0-1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
Hematologic function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
adequate blood functions: absolute neutrophil count (anc) ≥ 1.5 x 109/l, platelet count ≥ 100 x 109/l, and hemoglobin ≥ 9 g / dl
boolean
C0221130 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver Present
Item
adequate liver function: total bilirubin <1.5 times the upper limit of normal (uln); ast and alt <2.5 times uln in patients without liver metastases, <5 times uln in patients with liver metastases
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0494165 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0494165 (UMLS CUI [6,1])
C0150312 (UMLS CUI [6,2])
Renal function | Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula | Proteinuria | 24 hour urine sample | 24 Hour urine volume measurement
Item
adequate renal function: serum creatinine ≤ 1.25 times uln or calculated creatinine clearance ≥ 50 ml / min and urinary protein <2+. in patients with baseline urinary protein ≥ 2+, 24 hours urine should be collected and 24 hours urine protein ≤ 1g
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C2711451 (UMLS CUI [3])
C0033687 (UMLS CUI [4])
C0456209 (UMLS CUI [5])
C0427843 (UMLS CUI [6])
International Normalized Ratio | Prothrombin time assay
Item
international normalized ratio (inr) ≤ 1.5 and prothrombin time(pt) ≤ 1.5 times uln within 7 days before enrollment
boolean
C0525032 (UMLS CUI [1])
C0033707 (UMLS CUI [2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Bleeding tendency | Blood Coagulation Disorders
Item
evidence of bleeding diathesis or coagulopathy
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Hemoptysis
Item
history of hemoptysis, defined as bright red blood more than half a teaspoon 3 months before enrollment
boolean
C0019079 (UMLS CUI [1])
Prior Chemotherapy | Prior radiation therapy | Targeted Therapy biological
Item
previously received chemotherapy and radiotherapy and biological targeted therapy
boolean
C1514457 (UMLS CUI [1])
C0279134 (UMLS CUI [2])
C2985566 (UMLS CUI [3,1])
C0205460 (UMLS CUI [3,2])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure
Item
uncontrolled hypertension (systolic blood pressure> 150 mmhg and/or diastolic blood pressure> 100 mm hg)
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Cardiovascular Diseases | Cerebrovascular accident | Myocardial Infarction | Angina, Unstable | Congestive heart failure New York Heart Association Classification | Cardiac Arrhythmia Serious Requirement Pharmaceutical Preparations | Cardiac Arrhythmia Affecting Clinical Trial | Cardiac Arrhythmia Pharmacotherapy Unsuccessful
Item
clinically significant (ie, active) cardiovascular diseases, such as cerebrovascular accident (within 6 months before initiating treatment), myocardial infarction (within 6 months before initiating treatment), unstable angina, congestive heart failure (new york heart association class ≥grade ii) , serious arrhythmia which needs medication during the study and may affect the study or can not be controlled by drugs
boolean
C0007222 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0018802 (UMLS CUI [5,1])
C1275491 (UMLS CUI [5,2])
C0003811 (UMLS CUI [6,1])
C0205404 (UMLS CUI [6,2])
C1514873 (UMLS CUI [6,3])
C0013227 (UMLS CUI [6,4])
C0003811 (UMLS CUI [7,1])
C0392760 (UMLS CUI [7,2])
C0008976 (UMLS CUI [7,3])
C0003811 (UMLS CUI [8,1])
C0013216 (UMLS CUI [8,2])
C1272705 (UMLS CUI [8,3])
Wound, non-healed | Peptic Ulcer | Fracture
Item
unhealed wounds, active peptic ulcer or fracture
boolean
C0750433 (UMLS CUI [1])
C0030920 (UMLS CUI [2])
C0016658 (UMLS CUI [3])
Digestive System Fistula | Gastrointestinal perforation | Abdominal Abscess
Item
gastrointestinal fistula, gastrointestinal perforation or intra-abdominal abscess within 6 months before enrollment
boolean
C0079238 (UMLS CUI [1])
C0151664 (UMLS CUI [2])
C0243001 (UMLS CUI [3])
Gender Uterus Intact | Menopause Excluded | Contraceptive methods Unwilling | Intrauterine Devices | Vaginal Spermicides | Contraception, Barrier | Female Sterilization | Gender Contraceptive methods Unwilling
Item
women with intact uterus (menopause more than two years excluded) who are unwilling to take effective non-hormonal contraception (iud, spermicide barrier birth control device or sterilization) during the study. male who are unwilling to take effective contraceptive measures during the study
boolean
C0079399 (UMLS CUI [1,1])
C0042149 (UMLS CUI [1,2])
C0205266 (UMLS CUI [1,3])
C0025320 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0700589 (UMLS CUI [3,1])
C0558080 (UMLS CUI [3,2])
C0021900 (UMLS CUI [4])
C0087145 (UMLS CUI [5])
C0004764 (UMLS CUI [6])
C0015787 (UMLS CUI [7])
C0079399 (UMLS CUI [8,1])
C0700589 (UMLS CUI [8,2])
C0558080 (UMLS CUI [8,3])
Study Subject Participation Status
Item
participated in other clinical trials within 28 days before the initiation of treatment.
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs
Item
allergic to any of the study drugs
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial